These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21566454)

  • 1. [Successful optimal debulking surgery following chemotherapy combined with irinotecan hydrochloride and cisplatin for advanced clear cell carcinoma of the ovary].
    Hirakawa H; Futagami M; Yokoyama Y; Hakamada K; Mizunuma H
    Gan To Kagaku Ryoho; 2011 May; 38(5):857-60. PubMed ID: 21566454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of brain metastasis from advanced ovarian clear-cell carcinoma during maintenance chemotherapy with irinotecan+cisplatin].
    Takami M; Kita E; Kuwana Y; Ohta Y; Nakayama Y; Fukai H; Matsumoto H; Takimoto T; Ichikawa G; Yamamoto T
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1243-5. PubMed ID: 18633273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report.
    Saitoh-Sekiguchi M; Nakahara K; Kojimahara T; Ohta T; Kawagoe J; Ohnuki T; Hayasaka T; Motoyama T; Kurachi H
    Anticancer Res; 2007; 27(4C):2685-7. PubMed ID: 17695433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.
    Takano M; Kikuchi Y; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Sugiyama T
    Oncol Rep; 2006 Dec; 16(6):1301-6. PubMed ID: 17089053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.
    Takano M; Sugiyama T; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Kikuchi Y
    Int J Clin Oncol; 2007 Aug; 12(4):256-60. PubMed ID: 17701003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of advanced ovarian carcinosarcoma that responded remarkably to neoadjuvant chemotherapy of combined CPT-11 and CDDP].
    Takami M; Idei T; Nakayama Y; Ohta H; Fukai H; Matsumoto H; Togo Y; Sakamoto H; Yamamoto T; Satoh K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):305-8. PubMed ID: 11865639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of ovarian cancer in which a remarkable effect was seen with intrathoracic administration of CDDP and CPT-11].
    Tokumitsu S; Oka H; Nozaki A; Kanazawa T; Mukohara Y; Matsubara M; Matsushita K; Tsunashima T
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2237-8. PubMed ID: 19106582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer].
    Sugiyama T; Nishida T; Kataoka A; Imaishi K; Komai K; Ushijima K; Hasuo Y; Ookura N; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):827-34. PubMed ID: 8841050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinoma.
    Takakura S; Saito M; Ueda K; Motegi M; Takao M; Yamada K; Okamoto A; Niimi S; Sasaki H; Tanaka T; Ochiai K
    Int Surg; 2007; 92(4):202-8. PubMed ID: 18050828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma.
    Nishida M; Tsunoda H; Ichikawa Y; Yoshikawa H
    Int J Clin Oncol; 2004 Oct; 9(5):403-5. PubMed ID: 15549593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of papillary adenocarcinoma of the ovary that responded favorably to irinotecan hydrochloride and cisplatin after the administration of paclitaxel and carboplatin].
    Shimoya K; Kunishige I; Okuno Y; Hayashi S; Komura H; Arimoto Y; Otsuki Y
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):845-8. PubMed ID: 11432356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy.
    Kunito S; Takakura S; Nagata C; Saito M; Yanaihara N; Yamada K; Okamoto A; Sasaki H; Ochiai K; Tanaka T
    J Obstet Gynaecol Res; 2012 Dec; 38(12):1367-75. PubMed ID: 22639843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma.
    Nishino K; Aoki Y; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
    Gynecol Oncol; 2005 Jun; 97(3):893-7. PubMed ID: 15894369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of gastric adenosquamous carcinoma successfully treated with second-line chemotherapy (CPT-11 and CDDP)].
    Ishiguro A; Takahata T; Hirose K; Matsumoto Y; Tanaka S; Suzuki K; Hanada N; Itoh J; Kawasaki H; Kijima H; Fukuda S; Saijo Y
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1579-82. PubMed ID: 20716891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized chemotherapeutic regimen for each histological subtype of ovarian carcinoma.
    Shimizu Y
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():61-9. PubMed ID: 9210889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of gastric large cell neuroendocrine carcinoma (LCNEC) for whom chemotherapy of CDDP+CPT-11 proved very effective].
    Kirii Y; Ichikawa C; Miyamoto M; Hata M; Miyairi J; Takagi H; Fukushima M; Ota H
    Gan To Kagaku Ryoho; 2010 May; 37(5):895-8. PubMed ID: 20495323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.
    Nishikawa K; Fujitani K; Inagaki H; Akamaru Y; Tokunaga S; Takagi M; Tamura S; Sugimoto N; Shigematsu T; Yoshikawa T; Ishiguro T; Nakamura M; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Tsujinaka T
    Eur J Cancer; 2015 May; 51(7):808-16. PubMed ID: 25797356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful downstaging by a low-dose, fractional administration of irinotecan hydrochloride (CPT-11) in combination with cisplatin in peritoneal lavage cytology positive, 5-fluorouracil refractory advanced gastric cancer patients].
    Shimoyama S; Imamura K; Katayama A; Hiki N; Shimizu N; Yamaguchi H; Mafune K; Motoi T; Oohashi K; Kaminishi M
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):929-32. PubMed ID: 15222115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of successful control for primary duodenal cancer with combined CPT-11, CDDP and DOC chemotherapy].
    Satomi D; Morishima Y; Suzuki I; Aoki Y; Tazawa Y; Kobayashi J; Toyoda Y; Yoshida Y; Yamamoto K; Mori M; Nakano M
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1753-6. PubMed ID: 18931582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A recurrent ovarian cancer patient who achieved a complete response following irinotecan plus CDDP therapy].
    Kawashima T; Murakami H; Kanamori T; Nakamura Y
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):461-3. PubMed ID: 17353644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.